Last weeks with the gratest news this company ever had, I see we got plenty new investors showing up.
To help them with their DD over the weekend I will post some info that I have aquired over the last 15 months investing in this company.
Anyone has something to add here please feel free to chime in.
Here is something for start to let you know what is this all about;
this is from 2007 interview with Christopher Reinhard
but well worth reading;
Cardium Vision from CEO
<So Cardium Therapeutics was formed as a medical technology company, and we are initially focused on cardiovascular disease and Ischemic injury. And when we formed Cardium, we strongly felt that we wanted to build a little bit different kind of company, one that was not a classic binary tech bet, one that was not an exotic science play. But yet we were still very interested in acquiring forward looking drugs.
There is a clear issue in large pharma and large biotech looking for a new and exciting quite two drugs. So we do believe that there are companies very interested in acquiring forward looking drugs with big market opportunities. So we are not planning to develop Cardium as a fully integrated pharmaceutical or biotechnology company, but rather we are more like a holding company.
And the assets that we acquire, we acquire for them to be sold, to be distributed to our shareholders in different companies and so forth. So we've specifically looked at building a portfolio of these kinds of products that have different risks and different rewards, as we believe that you should have and built a more diversified platform in these companies.
We think one of the classic problems in biotech has been that people in biotech have not really thought of themselves as building businesses but rather, they've been [DC] backed and more than not focused on building technology. So, we are little bit different, our strongly has been to acquire undervalue product opportunities that have significant growth potential and we have been buying these technologies and product opportunities on highly favorable economic terms and as one of the keys.
We acquire things that we know we can bring value to and that we can change and transform in one way or the other, and to some how in one way or the other to change its risk profile, while they were holding the return profile relatively constant. So, it’s a part of our process.
If you look at our management team, we would look a little bit more like a classic private equity company or a classic venture capital fund, and that we have expertise in a broad range of areas. But what makes us a little more different is that we offer these companies. We actually run them...............................>
here some more for your DD this weekend;
I see with the latest price/volume action in this stock we have gained new investOrs and traders.
Anyone needs quick DD on the company may want to follow this tread as I posted here all you may want to know to help with your DD.